FinEdge Labs
A

ATR

ATRUnverified
6 segments tracked|5 years of data|Annual (10-K)
Total Revenue
$3.8B5.4%
FY2025
Operating Segments
6
Active segments
Blended Margin
0.0%
Operating margin
Highest Margin
0.0%
Pharma Segment
Segment Shift

Pharma Segment has grown from 0.0% to 46.0% of total revenue since FY2021, with 0.0% operating margins. Meanwhile, Beauty Segment is the fastest growing at +6.8% YoY.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2025

SegmentRevenueOp. IncomeMargin% of TotalYoY
Pharma Segment$1.7B$00.0%46.0%+5.7%
Beauty Segment$1.3B$00.0%34.7%+6.8%
Closures Segment$730M$00.0%19.3%+2.3%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free